To further explore the mechanism on anti-HCC effects of HMGB1 inhibition, immunoblot analysis of EMT associated transcription factors was performed and results indicated that ZEB1 was the most downregulated in HMGB1 deficient HCC cells (Figure 6A). Here, HMGB1 is linked to hepatocellular carcinoma.